These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 19040557)

  • 1. Enhancing aromatic L-amino acid decarboxylase activity: implications for L-DOPA treatment in Parkinson's disease.
    Hadjiconstantinou M; Neff NH
    CNS Neurosci Ther; 2008; 14(4):340-51. PubMed ID: 19040557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-Dihydroxyphenylalanine modulates the steady-state expression of mouse striatal tyrosine hydroxylase, aromatic L-amino acid decarboxylase, dopamine and its metabolites in an MPTP mouse model of Parkinson's disease.
    King JM; Muthian G; Mackey V; Smith M; Charlton C
    Life Sci; 2011 Oct; 89(17-18):638-43. PubMed ID: 21871902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatic L-amino acid decarboxylase modulation and Parkinson's disease.
    Neff NH; Hadjiconstantinou M
    Prog Brain Res; 1995; 106():91-7. PubMed ID: 8584678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCH 23390 enhances exogenous L-DOPA decarboxylation in nigrostriatal neurons.
    Neff NH; Wemlinger TA; Hadjiconstantinou M
    J Neural Transm (Vienna); 2000; 107(4):429-43. PubMed ID: 11215754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine modulates aromatic L-amino acid decarboxylase activity in mouse striatum.
    Neff NH; Wemlinger TA; Duchemin AM; Hadjiconstantinou M
    J Pharmacol Exp Ther; 2006 May; 317(2):480-7. PubMed ID: 16415089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatic L-amino acid decarboxylase in rat corpus striatum: implications for action of L-dopa in parkinsonism.
    Melamed E; Hefti F; Pettibone DJ; Liebman J; Wurtman RJ
    Neurology; 1981 Jun; 31(6):651-5. PubMed ID: 7195482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatic L-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors.
    Hadjiconstantinou M; Wemlinger TA; Sylvia CP; Hubble JP; Neff NH
    J Neurochem; 1993 Jun; 60(6):2175-80. PubMed ID: 8492125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine hydroxylase, aromatic L-amino acid decarboxylase and dopamine metabolism after chronic treatment with dopaminergic drugs.
    Cho S; Duchemin AM; Neff NH; Hadjiconstantinou M
    Brain Res; 1999 Jun; 830(2):237-45. PubMed ID: 10366680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization and functional significance of striatal neurons immunoreactive to aromatic L-amino acid decarboxylase or tyrosine hydroxylase in rat Parkinsonian models.
    Lopez-Real A; Rodriguez-Pallares J; Guerra MJ; Labandeira-Garcia JL
    Brain Res; 2003 Apr; 969(1-2):135-46. PubMed ID: 12676374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The localization and functional contribution of striatal aromatic L-amino acid decarboxylase to L-3,4-dihydroxyphenylalanine decarboxylation in rodent parkinsonian models.
    Nakamura K; Ahmed M; Barr E; Leiden JM; Kang UJ
    Cell Transplant; 2000; 9(5):567-76. PubMed ID: 11144954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonaminergic striatal neurons convert exogenous L-dopa to dopamine in parkinsonism.
    Melamed E; Hefti F; Wurtman RJ
    Ann Neurol; 1980 Dec; 8(6):558-63. PubMed ID: 6260009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nigrostriatal reduction of aromatic L-amino acid decarboxylase activity in MPTP-treated squirrel monkeys: in vivo and in vitro investigations.
    Yee RE; Huang SC; Stout DB; Irwin I; Shoghi-Jadid K; Togaski DM; DeLanney LE; Langston JW; Satyamurthy N; Farahani KF; Phelps ME; Barrio JR
    J Neurochem; 2000 Mar; 74(3):1147-57. PubMed ID: 10693947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease.
    Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
    Brain Res Rev; 2006 Sep; 52(2):244-56. PubMed ID: 16644019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial.
    Ciesielska A; Samaranch L; San Sebastian W; Dickson DW; Goldman S; Forsayeth J; Bankiewicz KS
    PLoS One; 2017; 12(2):e0169965. PubMed ID: 28166239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatic L-amino acid decarboxylase immunoreactive cells in the rat striatum: a possible site for the conversion of exogenous L-DOPA to dopamine.
    Mura A; Jackson D; Manley MS; Young SJ; Groves PM
    Brain Res; 1995 Dec; 704(1):51-60. PubMed ID: 8750961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of benserazide on L-DOPA-derived extracellular dopamine levels and aromatic L-amino acid decarboxylase activity in the striatum of 6-hydroxydopamine-lesioned rats.
    Shen H; Kannari K; Yamato H; Arai A; Matsunaga M
    Tohoku J Exp Med; 2003 Mar; 199(3):149-59. PubMed ID: 12703659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites.
    Alachkar A; Brotchie JM; Jones OT
    Neurosci Res; 2010 Sep; 68(1):44-50. PubMed ID: 20542064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopa-decarboxylase gene polymorphisms affect the motor response to L-dopa in Parkinson's disease.
    Devos D; Lejeune S; Cormier-Dequaire F; Tahiri K; Charbonnier-Beaupel F; Rouaix N; Duhamel A; Sablonnière B; Bonnet AM; Bonnet C; Zahr N; Costentin J; Vidailhet M; Corvol JC
    Parkinsonism Relat Disord; 2014 Feb; 20(2):170-5. PubMed ID: 24216088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopa-decarboxylation in the striata of rats with unilateral substantia nigra lesions.
    Kang UJ; Park DH; Wessel T; Baker H; Joh TH
    Neurosci Lett; 1992 Nov; 147(1):53-7. PubMed ID: 1480324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonistic actions of renal dopamine and 5-hydroxytryptamine: effects of amine precursors on the cell inward transfer and decarboxylation.
    Soares-da-Silva P; Pinto-do-O PC
    Br J Pharmacol; 1996 Mar; 117(6):1187-92. PubMed ID: 8882614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.